DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Pyrogen Testing Market - Opportunities and Forecast, 2014 - 2022" report to their offering.
Pyrogen is a thermostable bacterial toxin that induces immunogenic response when administered parenterally. Pyrogen testing is a process that determines the presence of bacterial toxins in vaccines, biotechnological products, and drugs, which induces fever in humans. It also determines the presence of microbes and their metabolites in drugs during the manufacturing process. Pyrogen testing is carried out during drugs and vaccine manufacturing process to prevent contamination and to ensure the absence of toxic molecular products.
Growing pharmaceutical, biotechnology and medical devices industry, increasing R&D investments, and favorable government policies are driving the growth of the world pyrogen testing market. However, strict regulatory norm acts as a restraint for the growth of the market. In addition, increasing outsourcing activities in the pharmaceutical industry across the developing countries would provide opportunities to the market.
The leading market players profiled in the report are Associates of Cape Cod Inc., Lonza Group, Charles River Laboratories International Inc., Hyglos GMBH, Merck & Co. Inc., Ellab A/S, Genscript, Sigma-Aldrich Corporation, Wako Chemicals USA Inc., and Thermo Fisher Scientific Inc.
These companies have implemented various strategies such as agreements, collaborations, product launches and partnerships to strengthen their position in the market.
Scope of the Report
World Pyrogen Testing Market By Product
- Kits & Reagents
World Pyrogen Testing Market By Test
- In Vitro tests
- Limulus amebocyte lysate (LAL) tests
- Rabbit tests
World Pyrogen Testing Market By Application
- Pharmaceutical & Biologics
- Medical Devices
- Other applications
For more information about this report visit http://www.researchandmarkets.com/research/vwlnj4/world_pyrogen